Journal Information

Statistics

Follow this link to access the full text of the article

REVISIÓN
Nemolizumab: un innovador tratamiento biológico para el control de la interleuquina 31 (IL-31) clave en la dermatitis atópica y el prurigo nodular
Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis
E. Serra-Baldricha,
Corresponding author
ESerra@santpau.cat

Autor para correspondencia.
, L.F. Santamaría-Babíb, J. Francisco Silvestrec
a Servicio de Dermatología, Hospital Sant Pau, Universidad Autónoma de Barcelona, Barcelona, España
b Inmunología Traslacional, Parque Científico de Barcelona, Universidad de Barcelona, Barcelona, España
c Servicio de Dermatología, Hospital General de Alicante, Alicante, España
Read
10928
Times
was read the article
3056
Total PDF
7872
Total HTML
Share statistics
Article information
ISSN: 00017310
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2024 July 216 77 293
2024 June 361 147 508
2024 May 314 111 425
2024 April 302 107 409
2024 March 317 106 423
2024 February 379 84 463
2024 January 370 109 479
2023 December 319 85 404
2023 November 335 169 504
2023 October 393 145 538
2023 September 335 93 428
2023 August 305 67 372
2023 July 306 91 397
2023 June 228 87 315
2023 May 283 126 409
2023 April 204 95 299
2023 March 243 73 316
2023 February 224 71 295
2023 January 212 126 338
2022 December 172 118 290
2022 November 216 123 339
2022 October 182 107 289
2022 September 178 100 278
2022 August 232 131 363
2022 July 286 143 429
2022 June 181 46 227
2022 May 187 44 231
2022 April 134 45 179
2022 March 156 72 228
2022 February 154 66 220
2022 January 131 72 203
2021 December 17 20 37
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?